Press Releases

05 May '22
First quarter GAAP diluted EPS of $0.17 ; non-GAAP diluted EPS of $0.13 Closed the sale of Hospital & Large Physician Practices business segment to Constellation Software Generated $35 million of cash flow from continuing operations in the quarter CHICAGO --(BUSINESS WIRE)--May 5, 2022-- Allscripts
21 Apr '22
CHICAGO --(BUSINESS WIRE)--Apr. 21, 2022-- Allscripts Healthcare Solutions, Inc . (NASDAQ:MDRX) will report its financial results for the three months ended March 31, 2022 after the close of stock market hours on Thursday, May 5, 2022 . Allscripts management plans to host a conference call and
04 Nov '21
Third quarter GAAP diluted EPS of $0.12 ; non-GAAP diluted EPS of $0.27 , up 145% year-over-year Generated $57 million of cash flow from continuing operations and $35 million of free cash flow in the third quarter Increasing 2021 outlook for Adjusted EBITDA and free cash flow CHICAGO --(BUSINESS

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com